5 hasil untuk "Yanli Mo"
Menampilkan 1–5 · 0,37 detik · RSS
-
Artikel Jurnal
Characterization of the complete chloroplast genome of Bupleurum komarovianum Lincz. 1950 (Apiaceae)
Bupleurum komarovianum is distributed in northeastern China and has occasionally been used as a substitute for the official Radix Bupleuri due to its morphological similarity and comparable pharmacologically active constituents. To facilitate its accurate identification, the complete chloroplast…
-
Artikel Jurnal
A bibliometric analysis of artificial intelligence applied to cervical cancer
ObjectiveThis study conducts a bibliometric analysis of artificial intelligence (AI) applications in cervical cancer to provide a comprehensive overview of the research landscape and current advancements.MethodsRelevant publications on cervical cancer and AI were retrieved from the Web of Science…
-
Artikel Jurnal
Global trends and academic landscapes of ultrasound applications in lung cancer research: a bibliometric analysis (2000–2024)
Abstract Objective This study aims to systematically evaluate the global distribution, academic impact, and technological trends of ultrasound technology in lung cancer research from 2000 to 2024 through bibliometric analysis, providing references for future research directions. Materials and…
-
Artikel Jurnal
MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells
Background and objective Lung cancer is the leading cause of cancer-related deaths worldwide, and metastasis is the major cause of death in lung cancer patients. MiR-373 is closely associated with invasion and metastasis in other tumor cells. This study explored the expression of miR-373-3p in…
-
Artikel Jurnal
Third‐Generation EGFR‐TKIs in T790M‐Negative NSCLC After First/Second‐Generation EGFR‐TKI Failure: A Retrospective Study
ABSTRACT Purpose In non‐small cell lung cancer (NSCLC) patients resistant to first‐ or second‐generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), only half develop the T790M mutation and thus qualify for the treatment using third‐generation EGFR‐TKIs. For…